Table 2:
Toxicity | N | % |
---|---|---|
Hyperglycemia | 4 | 13 |
Hypophosphatemia | 2 | 7 |
Lymphopenia | 2 | 7 |
Neutropenia | 1 | 3 |
Increased alanine aminotransferase | 1 | 3 |
Adverse events possibly, probably, or definitely attributed to perifosine, per patient (n=30)
Toxicity | N | % |
---|---|---|
Hyperglycemia | 4 | 13 |
Hypophosphatemia | 2 | 7 |
Lymphopenia | 2 | 7 |
Neutropenia | 1 | 3 |
Increased alanine aminotransferase | 1 | 3 |
Adverse events possibly, probably, or definitely attributed to perifosine, per patient (n=30)